All posts by medical

Neuroscience Antibody or Research Reagents Market Research Insights 2021 Global Industry Outlook Shared in Detailed Report, Forecast to 2030 Jumbo…

A new business intelligence report released by ResearchMoz with title Neuroscience Antibody or Research Reagents Market Insights, Forecast to 2025 provides latest updates and strategic steps taken by competition along with growth estimates of market size. The Neuroscience Antibody or Research Reagents Market report gives clear visions how the research and estimates are derived through primary and secondary sources considering expert opinion, patent analysis, latest market development activity and other influencing factors.

The market report envelopes an all-in information of the global Neuroscience Antibody or Research Reagents market and the nature of the market growth over the foreseeable period. The report provides a comprehensive elaboration of the positives and negatives of the global Neuroscience Antibody or Research Reagents market with DROT and Porters Five Forces analysis. With SWOT analysis, the report offers detailed insights about different players operating within the Neuroscience Antibody or Research Reagents market. In addition, the analysts of the report have served the qualitative and quantitative scrutinizing of different micro- and macro-economic factors influencing the global Neuroscience Antibody or Research Reagents market.

Request Discount on this Report @ https://www.researchmoz.com/enquiry.php?type=D&repid=2960075&source=atm

Market Overview of Neuroscience Antibody or Research Reagents

If you are involved in the Neuroscience Antibody or Research Reagents industry or aim to be, then this study will provide you inclusive point of view. Its vital you keep your market knowledge up to date segmented by major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.

Key players in the global Neuroscience Antibody or Research Reagents market covered in Chapter 12:GenscriptThermo Fisher ScientificWuhan Fine Biotech Co., Ltd.NEOBIOSCIENCE

This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts, understanding current investments cycle and impact of COVID-19 and slowdown. The report presents the market competitive landscape and in depth analysis of the major vendor/key players in the market along with their strategies to overcome production cycle issue and supply chain management to make process efficient.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2960075&source=atm

Key segments covered in the global Neuroscience Antibody or Research Reagents market report by product type include

The Neuroscience Antibody or Research Reagents market report examines the consumption patter of each segment and the factors affecting the pattern. In addition, the report focuses on the production footprint of each segment in various industries and regions across the globe.

The Neuroscience Antibody or Research Reagents market report helps the readers grasp the changing trend in the industry supply chain, manufacturing techniques and expenses, and current scenario of the end uses in the global Neuroscience Antibody or Research Reagents market.

In Chapter 4 and 14.1, on the basis of types, the Neuroscience Antibody or Research Reagents market from 2015 to 2025 is primarily split into:AntibodyResearch Reagents

In Chapter 5 and 14.2, on the basis of applications, the Neuroscience Antibody or Research Reagents market from 2015 to 2025 covers:Anti-ParkinsonAlzheimerPsychoticEpilepticOthers

Furthermore, the years considered for the study are as follows:

Historical year 2014-2019

Base year 2019

Forecast period** 2020 to 2025 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2960075&licType=S&source=atm

Important Features that are under offering & key highlights of the Neuroscience Antibody or Research Reagents market report:

Major Highlights of TOC:

Chapter One: Market Overview

1.1. Introduction

1.2. Scope/Objective of the Study

Chapter Two: Executive Summary

2.1. Introduction

Chapter Three: Market Dynamics

3.1. Introduction

3.2. Market Drivers, Trends, Challenges, Opportunities

Chapter Four: Market Factor Analysis

4.1. Porters Five Forces

4.2. Supply/Value Chain

4.3. PESTEL analysis

4.4. Market Entropy

4.5. Impact Analysis Post COVID-19

Chapter Nine: Methodology and Data Source

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, West Europe or Southeast Asia.

Contact Us:

ResearchMoz

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

See the original post:
Neuroscience Antibody or Research Reagents Market Research Insights 2021 Global Industry Outlook Shared in Detailed Report, Forecast to 2030 Jumbo...

Genetics the next frontier of healthcare – Bangkok Post

China is banking on genetics as the next frontier of modern healthcare. From genetic testing and sequencing to gene therapy and precision medicine, this range of transformative technologies and services can underpin medical treatments and inform lifestyle choices.

Precision medicine -- using genetic information to determine treatments -- enables healthcare to move away from a one-size-fits-all approach where patients are treated with the same therapy, to one where targeted treatments are based on a patient's DNA and biomarkers.

The Chinese government and private sector are leading the charge globally, encouraging nationwide collection of DNA samples and investing in data analysis tools.

The Beijing Genome Institute, the world's largest sequencer and repository of genetic material, says it is capable of decoding the entire genomes of 100,000 people a year for no more than US$100 per person. In 2017, genetic testing was listed in China's 13th Five-Year Plan as one of the key growth strategies for the life sciences sector.

While some companies continue to work on breakthrough technology for whole-genome sequencing, others are focusing on the direct-to-consumer DNA test industry that only analyses small sections of a person's DNA. These consumer tests are marketed at younger people who are interested in their genealogy or are seeking health predictions and suggestions for lifestyle adjustments.

For as little as $3, you can provide a saliva sample to a company in exchange for information such as risks of developing chronic illnesses, how to lose weight and how to care for your skin. This market is expected to generate sales of $405 million in China by next year.

Last December, the consumer genetic testing company Genebox raised $14 million in financing. It has lowered the price a DNA test to 19.90 yuan ($3) since entering the market in 2018. More than 2.2 million people in China had used Genebox's service as of the end of 2019. This number is forecast to increase to 56.8 million by 2022, according to the consultancy Yi Ou.

As mass-market genetic testing becomes more commonplace, and the Chinese government ramps up efforts to develop its national DNA database, observers have raised the issue of privacy and personal data protection.

Companies such as Genebox have committed to not sharing personal information with third parties. However, exceptions exist, including having to comply with laws and regulations, as well as sharing user data with subsidiaries and related organisations for medical research and product development purposes.

Currently, China does not have specific legislation in place to protect personal data, including genetic data, at the national level. However, regulations are being developed. The Standing Committee of the National People's Congress of China has outlined a legislative agenda for a data protection law that is set to be enacted next year.

Overcoming data privacy concerns will be key to unleashing the full benefits of genetic testing. Structural efforts should be made to overcome these issues, such as transparency over how such powerful personal data is used. Close collaboration is needed between genetic testing companies, doctors, patient rights advocates, regulatory agencies and insurers.

Although precision medicine is still in its infancy, it is attracting great interest, including from Thailand. I hope the new privacy laws due to be introduced this year are broad enough to cover these emerging technologies so that we are ready to protect people once they become mainstream.

See original here:
Genetics the next frontier of healthcare - Bangkok Post

Canine genetics, health to be explored at summit – VeterinaryPracticeNews.com

Preserving and enhancing genetic diversity in dog breeds is set to be explored at an upcoming virtual educational conference.

Scheduled for Feb. 15 and 16, Embark Veterinarys Canine Health Summit will feature presentations, panel discussions, and interactive sessions presented by various experts across the canine health landscape.

The free event, which targets veterinarians, breeders, and pet owners, will also include a keynote address by Duke University professor, Brian Hare, PhD, MA. Additionally, a roundtable discussion led by the Westminster Kennel Club will explore the history of purebred dogs, and how breeders and owners can work together to improve the long term health and vitality of specific breeds.

This summit is an opportunity to bring together a diverse group of stakeholders who are all committed to canine health and discuss ways to work together to accelerate the pace of discovery in the future, says Embarks chief science officer, Adam Boyko, PhD.

In lieu of registration fees, attendees are invited to contribute to the summits fundraiser, benefiting Morris Animal Foundation to support canine health research. Embark will also provide a matching donation of up to $5,000, the company says.

Morris Animal Foundation, as part of its research portfolio, has a long history of investing in canine genetics research to advance the health of dogs, says the foundations chief development officer, Ryan Welch. Were deeply appreciative of the generosity of Embark, and participants in the Canine Health Summit, for their contributions to help ensure this work continues.

To register, click here.

Original post:
Canine genetics, health to be explored at summit - VeterinaryPracticeNews.com

Front Range Biosciences Introduces A New Class of THCv Genetics That Will Boost Market Opportunities for New Consumer Experiences and Functional…

BOULDER, Colo., Feb. 9, 2021 /PRNewswire/ -- Front Range Biosciences ("FRB"), a cannabis and hemp genetics platform company, leveraging next generation breeding technology and R&D, todaybecame one of the first genetics providers to launch a new product line of high THCv plant varieties, in California, with availability in Colorado through licensed partners leveraging FRB's technology platform. This first generation product line is among the highest producers of THCv available, containing more than 20% total cannabinoids, more than 8% THCv, and over 2% grassy and fruity terpenes. These new varieties yield twice the yield of typical THCv producing plants. THCv is rare and has been an elusive minor cannabinoid until now, with exciting new properties for consumers that report appetite suppression and energizing, less psychoactive experiences.

"FRB is continually developing new genetics to help growers, brands, and consumers find new applications for cannabis," said Dr. Jonathan Vaught, CEO of Front Range Biosciences. "The cannabis market is evolving quickly, and consumers are constantly looking for new and unique experiences, just like in other CPG industries. We are leveraging genomics driven breeding to rapidly develop new products for cannabis companies and brands, unlocking new product opportunities from the incredible diversity of chemistry this plant produces. THCv represents just one of many new products we are making more accessible to the supply chain from this versatile plant through breeding, and we have many other unique products in development for other potential categories like edible ingredients, nutraceuticals and even pharmaceuticals.

This is the first THCv product line from FRB's world-renowned breeding program and expansive cannabis genetics library. This revolutionary THCv variety will pave the way for more unique consumer products, medical research and therapeutics. There is also a growing body of research linking THCv to a number of potential therapeutic benefits, including regulating tremors and seizures in ALS and Parkinson's patients, blocking fight or flight responses in PTSD, and acting as an effective analgesic for treating pain and migraines.

Since FRB's strain debuted on the market in California, it has become a favorite among local consumers. "It has a smooth, spicy-sweet smoke that creates a functional high. The THCv allows me to stay focused throughout the day, and I love that it's the opposite of most cannabis flower and keeps the munchies at bay," said Tricia Goldberg.

FRB's latest offering makes THCv more accessible by providing genetics that drastically increase yields, significantly reduce harvest times, deliver a variety of terpenes for improved flavor, as well as produce significantly higher levels of THCv, compared to the limited number of other THCv genetics that are currently available. These improvements in the finished product profile will open the door for new product opportunities for THCv flower-based products including smokable flower, pre-rolls, and concentrates, providing exciting new experiences for cannabis consumers.

"THCv, along with other minor cannabinoids, terpenes, and even flavonoids, have been a challenging group of traits for breeders to develop while maintaining the level of vigor and yield needed to introduce these products into the supply chain effectively," says Dr. Reggie Gaudino, VP of R&D for Front Range Biosciences. "The many years of genomics and chemistry research our team has been committed to for cannabis is allowing us to help growers and product companies do so much more with the plant than what was possible, even just a few years ago."

Growers have faced challenges producing cannabis containing high THCv content. The price of THCv has remained high due to significant lack of supply, and product availability has been extremely limited. This new class of THCv genetic products provides a timely solution to both issues, creating lucrative opportunities for cultivators and operators.

About Front Range Biosciences Front Range Biosciences is a premier cannabis and hemp genetics platform company, creating and supporting innovative new products across multiple industries by combining next generation agricultural technologies with the world's top hemp and cannabis R&D program. FRB provides leading-edge solutions to growers, brands, and product manufacturers through its unique varieties of seeds, young plants, and technology licensing to drive product development and production efficiency for cannabis and hemp derived products. Since 2015, the company has been dedicated to creating new product opportunities and solving challenges throughout the supply chain by leveraging proprietary next generation breeding, chemistry, and tissue culture technologies. In addition to FRB's groundbreaking technology, the company has also established genetics services dedicated to the California market and a Shimadzu sponsored Hemp Center of Excellence with top-tier researchers to encourage further innovation in the industry. FRB is the company of choice for cultivators that demand unique, quality, consistent products. For more information on Front Range Biosciences, visit http://www.frontrangebio.com.

Media Contact MATTIO Communications [emailprotected]

SOURCE Front Range Biosciences

Excerpt from:
Front Range Biosciences Introduces A New Class of THCv Genetics That Will Boost Market Opportunities for New Consumer Experiences and Functional...

Our genetics shape the micro-organisms that live within us – Epigram

By Lucy Mahony, Fourth Year, Bioinformatics

Researchers from the University of Bristol have contributed to a study showing that our DNA influences which types of microbes live inside our gut. The study is a key piece in the puzzle of understanding our gut microbiomes and how they might play a significant role in influencing our health.

Humans are walking petri dishes, with millions of microbes covering both the inside and outside of our bodies. We have roughly the same number of micro-organisms living inside our gut as human cells in our entire body. These specific micro-organisms are referred to as our microbiome.

The microbiome is of considerable interest to scientists, due to its well-known effects on our immune health, mental well-being, drug metabolism and even risk of cancer. However, how exactly the microbiome does this and why people have different compositions of micro-organisms inside their gut is not fully understood.

This collaborative study, published in Nature Genetics, involved over twenty research groups from across the globe and sampling from over 18,000 participants. The report found that at least two genes have an impact in determining which microbes we have in our gut. Firstly, the lactase gene was identified. This gene influences the abundance of a bacterial species called Bifidobacteria, which helps us digest lactose. The second gene is called the fucosyl transferase gene. This gene determines the abundance of a species of bacteria called Ruminococcus torques.

Dr Wade, a lecturer at the University of Bristol, who was one of the researchers on this study commented: What surprised me was how complex these genetic signals were. It was already expected that our genetic make-up would have some kind of impact on our microbiome. However, rather than a simple relationship, this study showed that many of the genes impacting the microbiome also influence human traits, which then in turn further influence the microbes.

The study also used a technique called Mendelian Randomization when analysing their results. This technique has been pioneered in Bristol and allowed the researchers to look at the relationship between the microbiome and human disease occurrence. They found that people whose microbiome had a higher abundance of a group of bacteria called Actinobacteria and its subgroup Bifidobacterium, might be protected from developing ulcers. They also found that the presence of certain members of the bacterial family Oxalobacteraceae might protect people from rheumatoid arthritis.

To better understand the links between human genetics and the gut microbiome, Dr Wade explains that inter-disciplinary collaboration between genetic epidemiologists and microbiologists will be required. [] We are working hard to apply complex methods with inter-disciplinary collaboration to understand the causal role played by the gut microbiome and human health.

There is a plethora of future work required before we can fully understand these interactions and translate them into healthcare.

Featured Image: National Human Genome Research Institute / Microbiome

Do you think about ways to take care of your microbiome? If yes, what are they?

Visit link:
Our genetics shape the micro-organisms that live within us - Epigram

SOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA…

The collaboration with the Spanish Lung Cancer Group (Grupo Espaol de Cncer de Pulmn GECP), a Spanish cooperative group for the research on lung cancer, is to show the potential of SOPHiA Radiomics a groundbreaking application that analyzes medical images for research use put to use in an additional retrospective analysis of the data from the phase 2 NADIM clinical trial (NCT03081689) (the NADIM trial).

The NADIM trial, funded by Bristol-Myers Squibb and part of the European Union's Horizon 2020 research and innovation program, aimed to assess the antitumor activity and safety of neoadjuvant chemoimmunotherapy for resectable stage IIIA NSCLC. The important results recently published in TheLancet Oncology supported the addition of neoadjuvant nivolumab to platinum-based chemotherapy in patients with resectable stage IIIA NSCLC. This very aggressive type of cancer is unfortunately terminal in most patients with locally advanced staged disease; these results could therefore support a change of perception of locally advanced lung cancer as a potentially lethal disease to one that is curable.

Additional data are expected to be generated through the analysis of the radiology images of NADIM patients through the SOPHiA Radiomics Platform. These data will then be combined with clinical, biological, and genomics data, and multimodal machine learning models will be developed to predict response to neoadjuvant treatment, using baseline and pre-surgery data. The predictive analysis will also aim to stratify patient cohorts with regard to progression-free and overall survival.

"We are very happy to collaborate in this innovative and revolutionary project that opens the door to a new precision medicine. Certainly, this partnership will improve the knowledge relating to the treatment for this group of patients and will allow to approach the best prospects for curing early-stage non-small cell lung cancer (NSCLC)," said Dr. Mariano Provencio, Head of the Medical Oncology Department at Puerta de Hierro University Hospital in Madrid and lead investigator of the NADIM trial.

"We are very excited to apply our radiomics and multimodal analytics capabilities to such an important clinical question," said Prof. Thierry Colin, Vice-President of Radiomics Research at SOPHiA GENETICS. "In the Spanish Lung Cancer Group, we have found visionary partners that clearly see the promise of next-generation health data such as radiomics being married with tech-enabled solutions in artificial intelligence to generate entirely novel clinical insights for the benefit of oncology patients."

"Unlocking the synergistic potential of multimodal health data through artificial intelligence holds revolutionary promise for the future of personalized medicine in oncology and many other health conditions. We are inspired by the potential to positively impact on patients by supporting their care providers in predicting the best course of treatment," said Dr. Philippe Menu, Chief Medical Officer at SOPHiA GENETICS.

The NADIM trial involved 18 centers from the Spanish Lung Cancer Network that will contribute their data to the joint project.

Results from the additional analysis of NADIM trial data are expected to be available later this year.

About SOPHiA GENETICS

SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the universal SOPHiA Platform allows clinical researchers to act with precision and confidence. The company's innovative approach enables an ever-expanding community of over 1,000 institutions to benefit from knowledge sharing, fostering a new era in healthcare. SOPHiA's achievement is recognized by the MIT Technology Review's "50 Smartest Companies".

More info: SOPHiAGENETICS.COM, follow @SOPHiAGENETICS on Twitter.

About the Spanish Lung Cancer Group

The SLCG is an independent, non-profit, cooperative group founded in 1991 to promote the study and research of lung cancer. The group is composed of 525 medical professionalsoncologists, thoracic surgery specialists, radiotherapists and basic researchersand unites 177 public and private centers across Spain.The group has treated over 37,000 patients in different studies and clinical trials, the results of which have been presented and published at national and international congresses and in leading medical journals.

More info: gecp.com, follow @gecp_org on Twitter.

SOPHIA GENETICS Media ContactSophie ReymondPR & Communications Manager [emailprotected]+41 79 863 11 10

SLCG ContactRita Perales [emailprotected] +34 670 24 70 50

SOURCE SOPHiA GENETICS

Homepage

Read the original here:
SOPHiA GENETICS and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA...

Science reveals genetic reasons behind different face shapes – Open Access Government

The human face has endless ways of existing, this immense variation witnessed for centuries across ethnicities and continents, across gender and language barriers.

Despite this multitude of ways to have a face, the global cosmetic surgery industry is expected to hit $50.5 billion by 2027.

It is currently the age of The Instagram Face leading individuals to pursue a specific set of features, which celebrity makeup artist Colby Smith described as: an overly tan skin tone, a South Asian influence with the brows and eye shape, an African-American influence with the lips, a Caucasian influence with the nose, a cheek structure that is predominantly Native American and Middle Eastern.

Despite how multicultural this ideal face appears, it is dismissive of genetic difference. The faces that are extensively crafted to look like this, via surgery or filter, have a racial ambiguity that disowns any real affiliation to race. This in itself is a worrying sentiment, as darker skinned people across the world remain at risk of discrimination.

Researchers in this study wanted to understand the legacy of the faces we have today where did they come from? And what could those genes tell them about ancestral adaptions of the face?

Recently, UCL researchers found 32 gene regions that influenced features such as nose, lip, jaw, and brow shape. Nine of these regions were completely new discoveries, while the others validated genes with little prior evidence.

The team analysed data from more than 6,000 volunteers across Latin America. This study compared genetic information from the study participants with characteristics of their face shape, quantified with 59 measurements (distances, angles and ratios between set points) from photos of the participants faces in profile.

The international research team, led from UCL, Aix-Marseille University and The Open University, found that one of the genes appears to have been inherited from the Denisovans. They are an extinct group of ancient humans, who lived tens of thousands of years ago.

The team found that the gene, TBX15, which contributes to lip shape, was linked with genetic data found in the Denisovan people, providing a clue to the genes origin.

One of the newly discovered genes found in this study is VPS13B, which influenced nose pointiness the researchers also found that this gene affects nose structure in mice. This further suggests there is a link between mammal gene influences.

Co-corresponding author Dr Kaustubh Adhikari (UCL Genetics, Evolution & Environment and The Open University) commented: The face shape genes we found may have been the product of evolution as ancient humans evolved to adapt to their environments. Possibly, the version of the gene determining lip shape that was present in the Denisovans could have helped in body fat distribution to make them better suited to the cold climates of Central Asia, and was passed on to modern humans when the two groups met and interbred.

The Denisovans lived in central Asia, and other studies suggest they interbred with modern humans, as some of their DNA lives on in Pacific Islanders and Indigenous people of the Americas.

Co-first author Dr Pierre Faux (Aix-Marseille University) said: To our knowledge this is the first time that a version of a gene inherited from ancient humans is associated with a facial feature in modern humans.

In this case, it was only possible because we moved beyond Eurocentric research; modern-day Europeans do not carry any DNA from the Denisovans, but Native Americans do.

Co-corresponding author Dr Kaustubh Adhikari (UCL Genetics, Evolution & Environment and The Open University) said: The face shape genes we found may have been the product of evolution as ancient humans evolved to adapt to their environments. Possibly, the version of the gene determining lip shape that was present in the Denisovans could have helped in body fat distribution to make them better suited to the cold climates of Central Asia, and was passed on to modern humans when the two groups met and interbred.

Read the full study here.

Editor's Recommended Articles

Read the original here:
Science reveals genetic reasons behind different face shapes - Open Access Government

Participants Needed for a Health and Behavior Study – University of Arkansas Newswire

Are you interested in learning more about how behavior impacts your health?

The Center for Human Nutrition and the Exercise is Medicine program at the University of Arkansas are recruiting adults over the age of 18 years to participate in research related to health and behavior.

The DFEND (Diet, Food, Exercise, and Nutrition During social distancing) research study is a 20-week education program which involves 30-minute educational meetings once per week, weekly health and behavior challenges, and the opportunity to meet weekly with personalized coaches.

Compensation for full participation for the first 75 people to sign up. Anyone can join the DFEND educational sessions for free without signing up for the research study.

For more information, please contact us atbaum@uark.eduorDFEND@uaex.eduor go to our websitehttps://aaes.uark.edu/centers-and-programs/nutrition/dfend-3/.

Read more from the original source:
Participants Needed for a Health and Behavior Study - University of Arkansas Newswire

To Fight COVID-19 Misinformation, WHO Is Partnering With Big Tech : Goats and Soda – NPR

Open up any social media app on your phone and you'll see it: links to COVID-19 information from trustworthy sources. Here, a Twitter screen reads, "No, 5G isn't causing coronavirus." Michele Abercrombie/NPR hide caption

Open up any social media app on your phone and you'll see it: links to COVID-19 information from trustworthy sources. Here, a Twitter screen reads, "No, 5G isn't causing coronavirus."

Open up any social media app on your phone and you'll likely see links to COVID-19 information from trustworthy sources.

Pinned to the top of Instagram's search function, the handles of the U.S. Centers for Disease Control and Prevention and the World Health Organization are prominently featured. Click and you'll find posts and stories how to keep safe during the pandemic.

In the home section of the YouTube app, there's a playlist of videos that promote vaccination and counteract vaccination misinformation from WHO, the Journal of the American Medical Association and GAVI, the Vaccine Alliance.

And on the Twitter app, you might spot a warning under posts with fake or misleading COVID-19 information. A tweet from a user falsely proclaiming that 5G causes coronavirus, for example, has a big blue exclamation mark with a message from Twitter: "Get the facts about COVID-19." It links to a story debunking the claim from a U.K. media outlet called iNews.

About Goats and Soda

Goats and Soda is NPR's global health and development blog. We tell stories of life in our changing world, focusing on low- and middle-income countries. And we keep in mind that we're all neighbors in this global village. Sign up for our weekly newsletter. Learn more about our team and coverage.

In the noisy news landscape, these are just some of the features launched by the tech industry to bring down COVID-19 misinformation and deliver facts to the public.

This effort didn't happen spontaneously. The World Health Organization sparked the efforts in Feb. 2020 in the early days of the coronavirus crisis. The U.N. agency teamed up with over 40 tech companies to help disseminate facts, minimize the spread of false information and remove misleading posts.

But there's one big question that's tough to answer: Is it working?

Have any of these efforts actually changed people's behavior in the pandemic or encouraged them to turn to more credible sources?

Health messaging experts and misinformation specialists interviewed for this story praise WHO's efforts to reach billions of people through these tech industry partnerships. But they say the actions taken by the companies have not been enough and may even be problematic.

Vish Viswanath, a professor of health communication in the department of social and behavioral sciences at the Harvard T.H. Chan School of Public Health, has been closely monitoring the global health content spread by the tech industry since the pandemic started.

"The WHO deserves credit for recognizing that the sheer flood of misinformation the infodemic is a problem and for trying to do something about it," he says. "But the tech sector has not been particularly helpful in stemming the tide of misinformation."

Researchers say there are limits to some of the anti-misinformation tactics used by social media companies.

Flagging or pulling down a problematic social media post often comes too late to undo the harm, says Nasir Memon, professor of computer science and engineering at New York University. His research includes cybersecurity and human behavior.

"It only comes after the post has gone viral. A company might do a fact check and put a warning label," he says. "But by then the ones who consumed that information already have been influenced in some way."

For example, in October, President Donald Trump claimed in a Twitter post that he had COVID-19 immunity after he was sick. According to the CDC: "There is no firm evidence that the antibodies that develop in response to SARS-CoV-2 infection are protective." The post was taken off Twitter after being flagged by fact-checkers but not before it had been shared with millions of his followers.

And there are no guarantees that people are going to take the time to click on a link to credible sources to "learn more," as the labels suggest, says Viswanath.

These "learn more" and "for more information" COVID-19 labels can be found on almost every tech platform yes, Twitter, Facebook and Instagram, but also Tinder, the dating app (every few swipes there are reminders to wash hands and observe physical distancing, with links to WHO messages) and Uber, the ridesharing app (a section on its website with rider safety information directs people to WHO for pandemic guidance).

"If I'm sitting in some community somewhere, busy with my life, worried about my job, worried about whether the kids are going to school or not, the last thing I want to do is go to a World Health Organization or CDC website," Viswanath adds.

WHO is aware these measures aren't perfect. Melinda Frost, with WHO's risk communication team, concedes that simply removing posts can create new problems. She shares a December study from the disinformation analytics company Graphika. It found that the crackdown on anti-vaccine videos on YouTube has led their proponents to repost the videos on other video-hosting sites like BitChute, favored by the far-right.

YouTube removes videos if they violate its COVID-19 policy. Videos that claim the COVID-19 vaccine kills people or will be used as a means of population reduction, for example, are not allowed. But other platforms may have less stringent policies.

"We may expect a proliferation of alternative platforms as fact checking and content removal measures are strengthened on social media," Frost says.

Researchers say it's hard to know whether any of these efforts have actually changed people's behavior in the pandemic or encouraged them to turn to more credible sources.

Claire Wardle, U.S. director of First Draft, a nonprofit organization that researches misinformation, says "we have almost no empirical evidence about the impact of these interventions on the platforms. We can't just assume that things that seem to make sense [such as taking a post down or directing people to a trustworthy source] would actually have the consequences we would expect."

Andy Pattison, who leads WHO's digital partnerships in Geneva, says the organization is now trying to assess impact.

WHO is working with Google, for example, on a questionnaire for users to see whether the company's efforts have resulted in behavior change and/or increased knowledge regarding COVID-19. Since the early days of the crisis, Google has ensured that users searching for "COVID" or related terms on its search engine see official news outlets and local health agencies in its top results, says Pattison.

In the absence of current data, past research can shed some light on social media misinformation.

For example, an April 2020 study from the NYU Tandon School of Engineering found that warning labels messages such as "multiple fact-checking journalists dispute the credibility of this news" can reduce people's intention to share false information. The likelihood, however, varied depending on the participant's political orientation and gender.

Memon, the lead author of the report, says the findings are relevant to social media policing in the pandemic. "Fact checking [on social media platforms] is going to become an important aspect of what we do as a society to help counter the spread of misinformation," he says.

Both Memon and Viswanath say with tens of millions of posts being shared on social media a day, companies need to scale up efforts to take down false information.

"They have the power. They have the reach. They should be more aggressive and active than they have been," says Viswanath.

Memon suggests that companies could deploy stronger mechanisms to verify users' identities. That could help prevent people from creating troll accounts to anonymously spread falsehoods and rumors, he says. And Viswanath suggests that tech companies hire teams of experts ethicists, researchers, scientists, doctors for advice on how to handle false information.

As for WHO, it's learned a key lesson during the pandemic. "Information alone is not going to shift behavior," says Frost, who has been working on WHO campaigns to debunk unjustified medical claims on social media.

So over the past few months, the organization has been gathering a group of sociologists, behavioral psychologists and neuroscientists to study how information circulates, how it can be managed and how it can change people's minds.

"A lot of what we know about behavior change really requires something closer to the individual making sure the information we have is relevant to individuals and makes sense in their lives," she says.

Continued here:
To Fight COVID-19 Misinformation, WHO Is Partnering With Big Tech : Goats and Soda - NPR

Love is in the air with Oatland wildlife center birds – Savannah Morning News

Eric Swanson| For Savannah Morning News

Musician John Paul Young once wrote Love is in the air, everywhere I look around. Love is in the air, every sight and every sound. As Valentine's Day approaches, the same could be said for the animals at Oatland Island Wildlife Center. While romantic love is debated as purely a human emotion, the rituals and behaviors of animals can be easily confused for love. So, since love is in the air, we thought we would take this opportunity to share some facts about the birds (but not the bees!) that call Oatland home.

Bird courtship rituals can look like human dating, with some species singing or dancing to impress a mate, others putting on flashy outfits by molting into bright feathers, still others provide tasty morsels to eat. The male Carolina wrens take things a bit further, asking females to move right in and start a family, building multiple nests to woo their partner. The building process and home showings display both their building skills as well as their excess energy which cues potential mates that they are successful food foragers.

At Oatland, the Carolina wrens have been seen building their nests, and it won't be long until we see females diligently incubating eggs. Listen for their loud teakettle, teakettle, teakettle call next time you visit, and you might spot them!

More: Match beak to food to boost your bird-watching buck

Owls are winter nesters and hoot wildly from high perches to maintain and define territory, which is then controlled by a bonded pair. They work together to find a suitable place to lay eggs, like a tree cavity or an abandoned nest, the male striving to impress the female by bringing her small rodents to eat. Owl species cooperate to raise their young with each member of the pair providing incubation and food.

For years, our barred owl, Wahoohoo, has laid one or two eggs within a week of Valentines Day. With no male present in the enclosure the eggs are always infertile, but she still heeds the biological cue to lay an egg every winter. Listen for the easy-to-remember barred owl hooting, Who cooks for you? Who cooks for you-all? and the great horned owl making a deep but soft hoo-ha HOO-hoo-hoo.

More: Find stars used on the underground railroad with Oatland Island astronomy night

If you have walked past the Oatland eagles recently you may have noticed two white eggs peeking up from their nest. Eagle eggs take approximately 35 days to incubate, with the female eagle minding the nest and tenderly turning the eggs with her beak. In the wild, many Southern bald eagle chicks hatch out near Valentine's Day. While our bald eagle pair, Arnold and Francesca, do appear to have bonded and tolerate each other's presence year-round (a rarity in the wild), the eggs laid every January have so far been found to be infertile. Whether the infertility is due to the human-made match or because of their poor balance due to past wing injuries, we can only speculate.

So, do bald eagles love? They do mate for life and return year after year to the same nest which takes a lot of commitment, so we will let you decide.

From flashy feathers to nest-building, a lot of bird behavior is driven by the biological urge to perpetuate their genes. In nature, if you have the skills to survive, your genes are valuable. While that simplification may not seem romantic for a pairing in human society, in the animal kingdom it is what matters the most. So this Valentines Day, though you may don your nicest clothes and secure a delicious meal for your partner, dont forget to delight in the human experience of conversation and connection. And, if youre looking for a great date idea, come check out the animal couples at Oatland Island Wildlife Center.

Eric Swanson is a naturalist at Oatland Island Wildlife Center. Learn more atoatlandisland.orgor on Facebook atoatlandisland.

See the original post here:
Love is in the air with Oatland wildlife center birds - Savannah Morning News